INTerpath-001: the science and what it means
View Professor Georgina Long’s presentation of the results of the INTerpath-001 personalised therapeutic cancer vaccine trial at ESMO, one of the world’s leading cancer conferences. It explains in clear terms what the trial tested, what it found, and what it means for people with melanoma.









